MediPharm Labs Corp. (TSX:LABS)

MediPharm Labs Statistics

Total Valuation

MediPharm Labs has a market cap or net worth of CAD 27.62 million. The enterprise value is 16.45 million.

Market Cap	27.62M
Enterprise Value	16.45M

Important Dates

The last earnings date was Monday, March 30, 2026.

Earnings Date	Mar 30, 2026
Ex-Dividend Date	n/a

Share Statistics

MediPharm Labs has 424.86 million shares outstanding. The number of shares has increased by 2.53% in one year.

Current Share Class	424.86M
Shares Outstanding	424.86M
Shares Change (YoY)	+2.53%
Shares Change (QoQ)	+0.23%
Owned by Insiders (%)	9.16%
Owned by Institutions (%)	0.00%
Float	385.94M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.61
PB Ratio	0.77
P/TBV Ratio	0.79
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-1.99
EV / Sales	0.36
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-2.94

Financial Position

The company has a current ratio of 2.77, with a Debt / Equity ratio of 0.01.

Current Ratio	2.77
Quick Ratio	1.90
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	-0.04
Interest Coverage	-114.59

Financial Efficiency

Return on equity (ROE) is -20.93% and return on invested capital (ROIC) is -27.96%.

Return on Equity (ROE)	-20.93%
Return on Assets (ROA)	-9.07%
Return on Invested Capital (ROIC)	-27.96%
Return on Capital Employed (ROCE)	-20.16%
Weighted Average Cost of Capital (WACC)	9.13%
Revenue Per Employee	355,307
Profits Per Employee	-65,094
Employee Count	127
Asset Turnover	0.91
Inventory Turnover	3.81

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -23.53% in the last 52 weeks. The beta is 0.87, so MediPharm Labs's price volatility has been lower than the market average.

Beta (5Y)	0.87
52-Week Price Change	-23.53%
50-Day Moving Average	0.07
200-Day Moving Average	0.07
Relative Strength Index (RSI)	48.12
Average Volume (20 Days)	200,031

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, MediPharm Labs had revenue of CAD 45.12 million and -8.27 million in losses. Loss per share was -0.02.

Revenue	45.12M
Gross Profit	13.86M
Operating Income	-7.22M
Pretax Income	-8.27M
Net Income	-8.27M
EBITDA	-5.59M
EBIT	-7.22M
Loss Per Share	-0.02

Balance Sheet

The company has 11.37 million in cash and 201,000 in debt, with a net cash position of 11.17 million or 0.03 per share.

Cash & Cash Equivalents	11.37M
Total Debt	201,000
Net Cash	11.17M
Net Cash Per Share	0.03
Equity (Book Value)	35.81M
Book Value Per Share	0.08
Working Capital	17.54M

Cash Flow

In the last 12 months, operating cash flow was -5.50 million and capital expenditures -100,000, giving a free cash flow of -5.60 million.

Operating Cash Flow	-5.50M
Capital Expenditures	-100,000
Depreciation & Amortization	1.63M
Net Borrowing	-192,000
Free Cash Flow	-5.60M
FCF Per Share	-0.01

Margins

Gross margin is 30.72%, with operating and profit margins of -16.00% and -18.32%.

Gross Margin	30.72%
Operating Margin	-16.00%
Pretax Margin	-18.32%
Profit Margin	-18.32%
EBITDA Margin	-12.40%
EBIT Margin	-16.00%
FCF Margin	n/a

Dividends & Yields

MediPharm Labs does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-2.53%
Shareholder Yield	-2.53%
Earnings Yield	-29.94%
FCF Yield	-20.29%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

MediPharm Labs has an Altman Z-Score of -2.37 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-2.37
Piotroski F-Score	3